表紙:ポイントオブケア (PoC) 診断
市場調査レポート
商品コード
1019937

ポイントオブケア (PoC) 診断

Point of Care Diagnostics

出版日: | 発行: Datamonitor Healthcare | ページ情報: 英文 121 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.72円
ポイントオブケア (PoC) 診断
出版日: 2021年06月28日
発行: Datamonitor Healthcare
ページ情報: 英文 121 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

体外診断 (IVD) 向けのポイントオブケア (PoC) 製品は、感染症や循環器・呼吸器・代謝系疾患の診断やスクリーニングなど、幅広い分野で活用されています。特に新型コロナウイルス感染症 (COVID-19) 検査の需要増大が市場を大きく成長させていますが、他の製品分野も市場成長に貢献すると考えられています。世界のPoC診断製品の市場規模は、予測期間中 (2020年~2025年) に190億米ドルから253億米ドルへと、5.9%のCAGRで増加すると予測されています。

当レポートでは、世界のポイントオブケア (PoC) 診断製品の市場について分析し、PoC診断の対象となる主な疾患や、主要製品の概略・活用法、全体的な市場規模の動向見通し、地域別・製品別の詳細動向などを調査しております。

目次

目次

エグゼクティブサマリー

第1章 臨床概要

  • 感染症検査
    • ヒト免疫不全ウイルス (HIV)
    • 結核
    • クラミジアトラコマチス/淋菌
    • ヒトパピローマウイルス (HPV)
    • メチシリン耐性黄色ブドウ球菌
    • 新型コロナウイルス (COVID-19)
    • その他の感染症
  • 心肺・心血管疾患検査
  • 糖尿病検査
  • がん検診
    • 結腸直腸がん
    • その他のがん
  • 止血検査
  • 乱用薬物検査
  • 妊娠・出産検査
  • その他の用途
  • 参考文献

第2章 ポイントオブケア (PoC) 診断製品

  • 技術の考察
    • 試験紙
    • イムノアッセイ
    • ラテラルフローアッセイ
    • マイクロ流体センサー
    • 分子技術
  • 感染症検査向けPoC診断製品
  • 血液ガス/電解質/代謝物検査向けPoC診断製品
  • 心臓マーカー検査向けPoC診断製品
  • 止血検査向けPoC診断製品
  • がん検診向けPoC診断製品
  • 妊娠・出産検査向けPoC診断製品
  • 薬物乱用検査向けPoC診断製品
  • 血糖値検査向けPoC診断製品
  • 他の用途向けPoC診断製品
  • 参考文献

第3章 ポイントオブケア (PoC) 診断市場の分析

  • 地域の考察
    • 米国
    • 欧州主要5ヶ国 (5EU)
    • 日本
    • 他の国々 (RoW)
  • PoC診断:製品分類別の市場予測
    • 競合分析
  • PoC診断製品の市場動向
  • 検査室で開発された試験
  • 市場促進・抑制要因
  • 血液ガス/電解質/代謝物検査向けPoC診断製品:市場分析
    • 競合分析
  • 心臓マーカー検査向けPoC診断製品:市場分析
  • 止血検査向けPoC診断製品:市場分析
  • 感染症検査向けPoC診断製品:市場分析
  • がん検診向けPoC診断製品:市場分析
  • 妊娠・出産検査向けPoC診断製品:市場分析
  • 薬物乱用検査向けPoC診断製品:市場分析
  • 血糖値検査向けPoC診断製品:市場分析
  • 他の用途向けPoC診断製品:市場分析
  • 参考文献

付録A:企業の収益動向

付録B:企業リスト

目次
Product Code: #MDT21007

Overview

Point of care in vitro diagnostics is being applied to an increasingly wide range of applications in infectious disease, cardiovascular, respiratory, and metabolic disease diagnosis and screening. The market is undergoing rapid expansion, primarily due to the demand for COVID-19 testing; however, other product segments will also contribute to market growth during the forecast period. This market is segmented into the following testing categories: blood gas/electrolyte/metabolite, cancer screening, cardiac, drugs of abuse, hemostasis, infectious disease, pregnancy/fertility, whole blood glucose, and miscellaneous other types. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the point of care diagnostics markets in the US, 5 Euro (France, Germany, Italy, Spain, and UK), Japan, and Rest of World markets. The market is projected to increase at a compound annual growth rate of 5.9%, from $19.0bn to $25.3bn during the 2020-25 forecast period covered by this report.

TABLE OF CONTENTS

Table of Contents

Executive Summary ............................................................................................................................ES-1

i. Introduction..............................................................................................................................ES-1

ii. Point of Care diagnostics products market .............................................................................ES-1

a. Blood gas/electrolyte/metabolite testing............................................................ES-4

b. Cardiac marker testing.........................................................................................ES-4

c. Hemostasis testing ...............................................................................................ES-4

d. Infectious disease testing ....................................................................................ES-4

e. Cancer screening..................................................................................................ES-5

f. Pregnancy and fertility testing..............................................................................ES-5

g. Drugs of abuse testing .........................................................................................ES-5

h. Whole blood glucose testing in diabetics............................................................ES-5

i. Other POC testing applications.............................................................................ES-5

iii. Market drivers and limiters....................................................................................................ES-6

iv. Technology trends ..................................................................................................................ES-6

v. Market leaders.........................................................................................................................ES-7

vi. Competitive strategies............................................................................................................ES-7

vii. Emerging competition ...........................................................................................................ES-8

viii. Methodology.........................................................................................................................ES-8

Exhibit ES-1: Point of care diagnostics, combined market forecast ($millions), by product segment, 2020-25 ........................................................................................ES-2

Exhibit ES-2: Point of care diagnostics, combined market forecast ($millions), by region, 2020-25...........................................................................................................................ES-3

1. Clinical Overview ............................................................................................................................. 1-1

1.1 Infectious disease testing....................................................................................................... 1-1

1.1.1 Human immunodeficiency virus...................................................................... 1-5

1.1.2 Tuberculosis..................................................................................................... 1-5

1.1.3 Chlamydia trachomatis/Neisseria gonorrhoea................................................ 1-6

1.1.4 Human papilloma virus.................................................................................... 1-6

1.1.5 Methicillin-resistant Staphylococcus aureus................................................... 1-7

1.1.6 Novel coronavirus (COVID-19)......................................................................... 1-7

1.1.7 Other infectious diseases................................................................................. 1-8

1.2 Cardiorespiratory and cardiovascular disease testing........................................................... 1-9

1.3 Diabetes testing ................................................................................................................... 1-10

1.4 Cancer screening.................................................................................................................. 1-11

1.4.1 Colorectal cancer........................................................................................... 1-15

1.4.2 Other cancers................................................................................................. 1-15

1.5 Hemostasis testing............................................................................................................... 1-17

1.6 Drugs of abuse testing ......................................................................................................... 1-17

1.7 Pregnancy and fertility testing............................................................................................. 1-19

1.8 Other applications................................................................................................................ 1-21

1.9 Bibliography ......................................................................................................................... 1-23

Exhibit 1-1: Incidence and prevalence of selected infectious diseases, by region.............................. 1-2

Exhibit 1-2: Cardiovascular disease mortality ('000), by region, 2011-2016...................................... 1-9

Exhibit 1-3: Prevalence of diabetes ('000), by region, 2010-2045.................................................... 1-11

Exhibit 1-4: Incidence of selected cancer types, by region, 2020 & 2040......................................... 1-13

Exhibit 1-5: Proportion of emergency department visits with reports of illicit drug use, US, 2006-2011 and 2020...................................................................................................... 1-18

Exhibit 1-6: Number of births (in millions), by country/region, 2020-2040 ..................................... 1-20

2. Point of Care Diagnostics Products.................................................................................................. 2-1

2.1 Technology Insights ............................................................................................................... 2-1

2.1.1 Dipsticks ................................................................................................ 2-1

2.1.2 Immunoassays....................................................................................... 2-1

2.1.3 Lateral flow assays ................................................................................ 2-2

2.1.4 Microfluidic sensors.............................................................................. 2-2

2.1.5 Molecular technologies......................................................................... 2-2

2.2 Point of care diagnostic products for infectious disease testing........................................... 2-3

2.3 Point of care diagnostic products for blood gas/electrolyte/metabolite testing.................. 2-7

2.4 Point of care diagnostic products for cardiac marker testing ............................................. 2-10

2.5 Point of care diagnostic products for hemostasis testing ................................................... 2-12

2.6 Point of care diagnostic products for cancer screening ...................................................... 2-15

2.7 Point of care diagnostic products for pregnancy and fertility testing................................. 2-17

2.8 Point of care diagnostic products for drugs of abuse testing.............................................. 2-19

2.9 Point of care diagnostic products for blood glucose testing ............................................... 2-22

2.10 Point of care diagnostic products for other applications................................................... 2-25

2.11 Bibliography........................................................................................................................ 2-27

Exhibit 2-1: Selected POC diagnostics products for infectious disease testing, 2021......................... 2-5

Exhibit 2-2: Selected POC diagnostic products for blood gas/electrolyte/metabolite testing, 2021 . 2-8

Exhibit 2-3: Selected point of care diagnostic products for cardiac marker testing, 2021 ............... 2-11

Exhibit 2-4: Selected point of care diagnostic products for hemostasis testing, 2021 ..................... 2-13

Exhibit 2-5: Selected point of care diagnostic products for cancer screening, 2021 ........................ 2-16

Exhibit 2-6: Selected point of care diagnostic products for pregnancy and fertility testing, 2021... 2-18

Exhibit 2-7: Selected point of care diagnostic products for drugs of abuse testing, 2021................ 2-20

Exhibit 2-8: Selected point of care diagnostic products for blood glucose testing, 2021................. 2-23

Exhibit 2-9: Selected point of care diagnostic products for other applications, 2021 ...................... 2-26

3. Point of Care Diagnostics Market Analysis ............................................................................ 3-1

3.1 Regional insights.................................................................................................................... 3-1

3.1.1 United States......................................................................................... 3-1

3.1.2 Five major European markets............................................................... 3-1

3.1.3 Japan...................................................................................................... 3-3

3.1.4 Rest of world ......................................................................................... 3-3

3.2 Point of care diagnostics, market forecast by product segment........................................... 3-3

3.2.1 Competitive analysis ............................................................................. 3-4

3.3 Trends in the point of care diagnostics products market...................................................... 3-3

3.4 Laboratory developed tests................................................................................................... 3-3

3.5 Market drivers and limiters ................................................................................................... 3-4

3.6 Products for blood gas/electrolyte/metabolite testing, market analysis.............................. 3-5

3.6.1 Competitive analysis ............................................................................. 3-7

3.7 Point of care diagnostics for cardiac marker testing, market analysis.................................. 3-8

3.7.1 Competitive analysis ........................................................................... 3-10

3.8 Point of care diagnostics for hemostasis testing, market analysis...................................... 3-11

3.8.1 Competitive analysis ........................................................................... 3-11

3.9 Point of care diagnostics for infectious disease testing, market analysis ........................... 3-14

3.9.1 Competitive analysis ........................................................................... 3-16

3.10 Point of care diagnostics for cancer screening, market analysis............................ 3-18

3.10.1 Competitive analysis ........................................................................... 3-18

3.11 Point of care diagnostics for pregnancy and fertility testing, market analysis...... 3-20

3.11.1 Competitive analysis ........................................................................... 3-21

3.12 Point of care diagnostics for drugs of abuse testing, market forecast................... 3-22

3.12.1 Competitive analysis ........................................................................... 3-23

3.13 Point of care diagnostics for blood glucose testing, market forecast.................... 3-24

3.13.1 Competitive analysis ........................................................................... 3-28

3.14 Point of care diagnostics for other applications, market forecast......................... 3-30

3.14.1 Competitive analysis ........................................................................... 3-33

3.15 Bibliography............................................................................................................ 3-36

Exhibit 3-1: Point of care diagnostics products, combined market forecast ($m), by region, 2020-25............................................................................................................................ 3-2

Exhibit 3-2: Point of care diagnostics products, combined market forecast ($m), by segment, 2020-25............................................................................................................................ 3-1

Exhibit 3-3: Point of care diagnostics products, combined market ($m), global share by supplier, 2020.................................................................................................................................. 3-2

Exhibit 3-4: Exact Sciences' home colorectal cancer screening service revenue ($m), 2015-20 ....... 3-4

Exhibit 3-5: Point of care diagnostics for blood gas/electrolyte/metabolite testing, market forecast ($m) by region, 2020-25........................................................................ 3-6

Exhibit 3-6: Market for point of care diagnostics products for blood gas/electrolyte/metabolite testing ($m), global share by supplier, 2020.................................................................... 3-7

Exhibit 3-7: Point of care diagnostics products for cardiac marker testing, market forecast ($m), by region, 2020-25........................................................................................................... 3-9

Exhibit 3-8: Market for point of care diagnostics products for cardiac marker testing, global share by supplier, 2020 ....................................................................................... 3-10

Exhibit 3-9: Point of care diagnostics products for hemostasis testing, market forecast ($m), by region, 2020-25......................................................................................................... 3-12

Exhibit 3-10: Point of care diagnostics products market for hemostasis testing, global share by supplier, 2020 ....................................................................................... 3-13

Exhibit 3-11: Point of care diagnostics products for infectious disease testing, market forecast ($m), by region, 2020-25..................................................................... 3-15

Exhibit 3-12: Point of care diagnostics products for infectious disease testing, global share by supplier, 2020 ....................................................................................... 3-17

Exhibit 3-13: Point of care diagnostics products for cancer screening, market forecast ($m), by region, 2020-25......................................................................................................... 3-19

Exhibit 3-14: Point of care diagnostics products for pregnancy and fertility testing, market forecast ($m), by region, 2020-25..................................................................... 3-20

Exhibit 3-15: Point of care diagnostics products for pregnancy and fertility testing, global share by supplier, 2020 ....................................................................................... 3-21

Exhibit 3-16: Point of care diagnostics products for drugs of abuse testing, market forecast ($m), by region, 2020-25......................................................................................................... 3-22

Exhibit 3-17: Point of care diagnostics products for drugs of abuse testing, global share by supplier, 2020 ....................................................................................... 3-23

Exhibit 3-18: Point of care diagnostics products for blood glucose testing, market forecast ($m), by region, 2020-25......................................................................................................... 3-25

Exhibit 3-19: Point of care diagnostics products for professional-use blood glucose testing, market forecast ($m), by region, 2020-25..................................................................... 3-26

Exhibit 3-20: Point of care diagnostics products for blood glucose self-testing, market forecast ($m), by region, 2020-25......................................................................................................... 3-27

Exhibit 3-21: Point of care diagnostics products for blood glucose testing, global share by supplier, 2020................................................................................................................................ 3-29

Exhibit 3-22: Point of care diagnostics products for other applications, market forecast ($m), by product segment, 2020-25 ....................................................................................... 3-31

Exhibit 3-23: Point of care diagnostics products for other applications, market forecast ($m) by region, 2020-25......................................................................................................... 3-32

Exhibit 3-24: Point of care diagnostics market for other applications, share by supplier, 2020 ...... 3-33

Exhibit 3-25: Point of care diagnostics market for hemoglobin and hematocrit testing, share by supplier, 2020 .................................................................................................. 3-34

Exhibit 3-26: Point of care diagnostics market for urinalysis products, share by supplier, 2020 ..... 3-34

Exhibit 3-27: Point of care diagnostics market for glycated hemoglobin testing products, share by supplier, 2020 .................................................................................................. 3-35

Exhibit 3-28: Point of care diagnostics market for allergy testing products, share by supplier, 2020 .................................................................................................. 3-35

APPENDIX A: COMPANY REVENUES...................................................................................................A-1

APPENDIX B: COMPANY LISTING........................................................................................................ B-1